CFTR Mutation Analysis (Pseudomonas aeruginosa Infection-Related Screening)
This test checks for specific genetic changes in the CFTR gene that may be linked to increased susceptibility to *Pseudomonas aeruginosa* infections, often associated with cystic fibrosis or other respiratory conditions.
["Helps identify genetic risks for certain infections that may require monitoring or treatment adjustments."]
Key facts at a glance
- LOINC
- 21655-6
- Short code
- CFTRF508
- Synonyms
- CFTR p.F508del Bld/T Ql
- Category
- chemistry
- Sample
- whole-blood
- Container
- EDTA (lavender/purple-top) tube for whole blood; sterile container for tissue specimens
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 0–999 years
- Method
- molgen
- CPT
- 81220
- SNOMED
- 4451000179102
- Specimen volume
- 3-5 mL whole blood in EDTA tube; minimum 1 mL for pediatric samples; tissue specimens require minimum 5 mg of tissue
- Stability
- Whole blood: stable for 7 days at 2-8°C; 30 days at -20°C; indefinite at -80°C. DNA extracted from specimen is stable for years when stored at -20°C or lower. Avoid repeated freeze-thaw cycles
- Hemolysis max
- 0
- Lipemia max
- 0
- Icterus max
- 0
- TAT
- 72–336 hours
- Order
- routine
What This Test Measures
The test detects the presence of the *CFTR p.F508del* mutation, a common genetic variant in the CFTR gene. This mutation can affect how the body processes certain substances, potentially increasing vulnerability to infections like *Pseudomonas aeruginosa*. Results may be qualitative (positive/negative) or confirmatory, depending on clinical context.
Why It Might Be Ordered
Your healthcare provider may recommend this test if you have symptoms of respiratory issues, recurrent infections, or a family history of cystic fibrosis or related genetic conditions. It’s sometimes used in screening for patients with chronic lung infections or those at higher risk due to genetic predisposition.
Sample Collection and Preparation
The test typically uses a blood sample (whole blood) to analyze DNA. A healthcare professional will draw blood, usually from a vein in your arm. The sample is then processed in a lab to identify the genetic mutation.
What to Expect Before the Test
No special preparation is usually needed, but you may be asked to avoid certain medications (like antibiotics) for a short time if directed by your provider. If you’re pregnant or have bleeding disorders, let your doctor know before the test.
Reference range
Negative (mutation not detected). Positive result indicates presence of the p.Phe508del mutation in one or both alleles (heterozygous or homozygous)N/A
No special preparation required. Informed consent for genetic testing is recommended prior to sample collection. Patients should be informed of the implications of genetic test results including potential impact on family members
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
◆Associated findings1
Short name
CFTR Gene Test for Pseudomonas Screening
Frequently asked questions
Will this test show if I already have an infection?
Can this test be used to diagnose cystic fibrosis?
What if my test result is positive for this mutation?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy